home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

285 rows where docket_id = "FDA-2016-N-2527" and posted_year = 2017 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

  • Supporting & Related Material 276
  • Other 8
  • Proposed Rule 1

posted_year 1

  • 2017 · 285 ✖

agency_id 1

  • FDA 285
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2016-N-2527-8031 FDA None FDA-2016-N-2527 Exhibit E-3 - Appendix B to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T15:02:42Z   0 0 09000064828d2eb3
FDA-2016-N-2527-8037 FDA None FDA-2016-N-2527 Exhibit G-4 - Attachment 3 to Second Supplement to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-09-07T17:45:09Z   0 0 09000064828d1da9
FDA-2016-N-2527-8030 FDA None FDA-2016-N-2527 Exhibit E-2 - Appendix A to Citizen Petion re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T14:23:15Z   0 0 09000064828d2eb2
FDA-2016-N-2527-8027 FDA None FDA-2016-N-2527 Exhibit C - re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T13:48:47Z   0 0 09000064828d2eaf
FDA-2016-N-2527-8029 FDA None FDA-2016-N-2527 Exhibit E-1 - Citizen Petition dated July 28, 2011 re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T14:11:01Z   0 0 09000064828d2eb1
FDA-2016-N-2527-8026 FDA None FDA-2016-N-2527 Exhibit B - re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T13:48:54Z   0 0 09000064828d2eae
FDA-2016-N-2527-8033 FDA None FDA-2016-N-2527 Exhibit F-2 - Appendix A to First Supplement to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T15:01:24Z   0 0 09000064828d1da5
FDA-2016-N-2527-8034 FDA None FDA-2016-N-2527 Exhibit G-1 - Second Supplement to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T15:00:28Z   0 0 09000064828d1da6
FDA-2016-N-2527-8032 FDA None FDA-2016-N-2527 Exhibit F-1 - First Supplement to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T15:01:54Z   0 0 09000064828d2eb4
FDA-2016-N-2527-8036 FDA None FDA-2016-N-2527 Exhibit G-3 - Attachment 2 to Second Supplement to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T14:59:32Z   0 0 09000064828d1da8
FDA-2016-N-2527-8028 FDA None FDA-2016-N-2527 Exhibit D - Analysis of NNN Proposed Rule re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T13:59:26Z   0 0 09000064828d2eb0
FDA-2016-N-2527-8035 FDA None FDA-2016-N-2527 Exhibit G-2 - Attachment 1 to Second Supplement to Citizen Petition re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-09T04:00:00Z 2017 8     2017-08-09T14:59:56Z   0 0 09000064828d1da7
FDA-2016-N-2527-8021 FDA None FDA-2016-N-2527 Exhibit A - Reference List re Comment from RAI Services Company Supporting & Related Material Background Material 2017-08-07T04:00:00Z 2017 8     2017-08-07T19:01:38Z   0 0 09000064828d2ead
FDA-2016-N-2527-2690 FDA None FDA-2016-N-2527 PRIA Reference 39 - Establishment Registration & Tobacco Product Listing Sample Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:12Z   0 0 0900006482605576
FDA-2016-N-2527-2651 FDA None FDA-2016-N-2527 PRIA Reference List (3) Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:23:46Z   0 0 090000648260527e
FDA-2016-N-2527-2663 FDA None FDA-2016-N-2527 PRIA Reference 12 - The Formation of Nitrosamines in Experimental Tobacco Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:26Z   0 0 090000648260535f
FDA-2016-N-2527-2660 FDA None FDA-2016-N-2527 PRIA Reference 9 - Are We Finally Winning the War on Cancer Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:13Z   0 0 090000648260550f
FDA-2016-N-2527-2653 FDA None FDA-2016-N-2527 PRIA Reference 2 - Statistical Report - Tobacco Report Symbol, 2015 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:49:44Z   0 0 0900006482605508
FDA-2016-N-2527-2655 FDA None FDA-2016-N-2527 PRIA Reference 4 - National Vital Statistical Reports, 2015 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:49:51Z   0 0 090000648260550a
FDA-2016-N-2527-2682 FDA None FDA-2016-N-2527 PRIA Reference 31 - U.S. Business Administration Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:43Z   0 0 090000648260556e
FDA-2016-N-2527-2664 FDA None FDA-2016-N-2527 PRIA Reference 13 - Code Date Catalog Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:31Z   0 0 0900006482605360
FDA-2016-N-2527-2676 FDA None FDA-2016-N-2527 PRIA Reference 25 - Topics for Biological and Biochemical Research Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:20Z   0 0 0900006482605560
FDA-2016-N-2527-2688 FDA None FDA-2016-N-2527 PRIA Reference 37 - Occupation Employment Statistics Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:04Z   0 0 0900006482605574
FDA-2016-N-2527-2652 FDA None FDA-2016-N-2527 PRIA Reference 1 - Combustible and Smokeless Tobacco Use Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:49:36Z   0 0 0900006482605507
FDA-2016-N-2527-2656 FDA None FDA-2016-N-2527 PRIA Reference 5 - Smoking and Tobacco Use, 2014 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:49:54Z   0 0 090000648260550b
FDA-2016-N-2527-2679 FDA None FDA-2016-N-2527 PRIA Reference 28 - Patients Perceived Health Status Following Primary Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:30Z   0 0 0900006482605563
FDA-2016-N-2527-2685 FDA None FDA-2016-N-2527 PRIA Reference 34 - Carcinogenic Tobacco Specific N-Nitrosamines in U.S Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:53Z   0 0 0900006482605571
FDA-2016-N-2527-2666 FDA None FDA-2016-N-2527 PRIA Reference 15 - Literature Study N-Nitrosamines in Tobacco Products Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:40Z   0 0 0900006482605362
FDA-2016-N-2527-2671 FDA None FDA-2016-N-2527 PRIA Reference 20 - SEER Cancer Statistics Review, 1975-2012 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:00Z   0 0 0900006482605367
FDA-2016-N-2527-2658 FDA None FDA-2016-N-2527 PRIA Reference 7 - Raising th Excise Tax on Cigarettes Effects on Health and the Federal Budget, 2012 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:05Z   0 0 090000648260550d
FDA-2016-N-2527-2680 FDA None FDA-2016-N-2527 PRIA Reference 29 - Reformulation Cost Model FINAL REPORT Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:35Z   0 0 0900006482605564
FDA-2016-N-2527-2659 FDA None FDA-2016-N-2527 PRIA Reference 8 - The 2015 Long Term Budget Outlook Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:09Z   0 0 090000648260550e
FDA-2016-N-2527-2661 FDA None FDA-2016-N-2527 PRIA Reference 10 - The Cost Effectiveness of Community Based Screening for Oral Cancer Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:18Z   0 0 0900006482605510
FDA-2016-N-2527-2675 FDA None FDA-2016-N-2527 PRIA Reference 24 - Regional Convenience Store Markup Percentages Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:17Z   0 0 090000648260555f
FDA-2016-N-2527-2683 FDA None FDA-2016-N-2527 PRIA Reference 32 - Statistics of US Businesses 2013 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:46Z   0 0 090000648260556f
FDA-2016-N-2527-2691 FDA None FDA-2016-N-2527 PRIA Reference 40 - FDA's Electronic Reading Room - Warning Letters Sample Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:16Z   0 0 0900006482605577
FDA-2016-N-2527-2662 FDA None FDA-2016-N-2527 PRIA Reference 11 - An Interim Determination of Health Gain from Oral Cancer Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:21Z   0 0 090000648260535e
FDA-2016-N-2527-2669 FDA None FDA-2016-N-2527 PRIA Reference 18 - Is Addiction Rational Theory and Evidence Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:53Z   0 0 0900006482605365
FDA-2016-N-2527-2654 FDA None FDA-2016-N-2527 PRIA Reference 3 - Adjusting the Value of a Statistical Life Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:49:47Z   0 0 0900006482605509
FDA-2016-N-2527-2684 FDA None FDA-2016-N-2527 PRIA Reference 33 - Tobacco-Specific Nitrosamines in New Tobacco Products Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:50Z   0 0 0900006482605570
FDA-2016-N-2527-2668 FDA None FDA-2016-N-2527 PRIA Reference 17 - Tobacco and the Economy Farms, Jobs and Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:49Z   0 0 0900006482605364
FDA-2016-N-2527-2687 FDA None FDA-2016-N-2527 PRIA Reference 36 - CPI Report 2015 Dec Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:00Z   0 0 0900006482605573
FDA-2016-N-2527-2692 FDA None FDA-2016-N-2527 PRIA Reference 41 - Informing the NNN Product Standard RIA Memo Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:19Z   0 0 090000648260558b
FDA-2016-N-2527-2665 FDA None FDA-2016-N-2527 PRIA Reference 14 - Recurrence Rate and Shift in Histopathological Differentiation of Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:36Z   0 0 0900006482605361
FDA-2016-N-2527-2667 FDA None FDA-2016-N-2527 PRIA Reference 16 - Prospective Investigation of the Cigarette Smoking Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:44Z   0 0 0900006482605363
FDA-2016-N-2527-2670 FDA None FDA-2016-N-2527 PRIA Reference 19 - Report of Nationally Representative Values for the Non Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:56Z   0 0 0900006482605366
FDA-2016-N-2527-2657 FDA None FDA-2016-N-2527 PRIA Reference 6 - Smoking and Tobacco Use, 2015 Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:50:02Z   0 0 090000648260550c
FDA-2016-N-2527-2686 FDA None FDA-2016-N-2527 PRIA Reference 35 - 50 Year Trends in Smoking Related Mortality in the U.S Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:57Z   0 0 0900006482605572
FDA-2016-N-2527-2689 FDA None FDA-2016-N-2527 PRIA Reference 38 - Federal Trade Commission Smokeless Tobacco Product Report Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:08Z   0 0 0900006482605575
FDA-2016-N-2527-2677 FDA None FDA-2016-N-2527 PRIA Reference 26 - The Determination of Tobacco Specific Nitrosamines in Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:24Z   0 0 0900006482605561
FDA-2016-N-2527-2678 FDA None FDA-2016-N-2527 PRIA Reference 27 - Valuing Reductions in Fatal Illness Risks Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:27Z   0 0 0900006482605562
FDA-2016-N-2527-2681 FDA None FDA-2016-N-2527 PRIA Reference 30 - FDA Labeling Cost Model FINAL Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:38Z   0 0 0900006482605565
FDA-2016-N-2527-2693 FDA None FDA-2016-N-2527 PRIA Reference 42 - Crop Production 2014 Summary Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:52:23Z   0 0 090000648260558c
FDA-2016-N-2527-2672 FDA None FDA-2016-N-2527 PRIA Reference 21 - The Incentives Created by a Harm Reduction Approach Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:03Z   0 0 090000648260555c
FDA-2016-N-2527-2673 FDA None FDA-2016-N-2527 PRIA Reference 22 - Proposal for Basic Research on Tobacco Fermentation Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:07Z   0 0 090000648260555d
FDA-2016-N-2527-2674 FDA None FDA-2016-N-2527 PRIA Reference 23 - The Value of Health and Longevity Supporting & Related Material Background Material 2017-05-23T04:00:00Z 2017 5     2017-05-23T16:51:13Z   0 0 090000648260555e
FDA-2016-N-2527-0259 FDA None FDA-2016-N-2527 Letter from Robert Ellis to FDA Other Letter(s) 2017-03-16T04:00:00Z 2017 3 2017-03-16T04:00:00Z   2017-03-16T16:19:44Z   0 0 09000064825011b0
FDA-2016-N-2527-0268 FDA None FDA-2016-N-2527 Request to Extend Comment Period from RAI Services Company Other Request for Extension 2017-03-16T04:00:00Z 2017 3 2017-03-16T04:00:00Z   2017-03-16T16:34:58Z   0 0 0900006482509dbd
FDA-2016-N-2527-0269 FDA None FDA-2016-N-2527 Request to Extend Comment Period from Reason Foundation Other Request for Extension 2017-03-16T04:00:00Z 2017 3 2017-03-16T04:00:00Z   2017-03-16T16:35:11Z   0 0 090000648250a4d0
FDA-2016-N-2527-0255 FDA None FDA-2016-N-2527 Letter from The Honorable Andy Barr to DHHS Other Letter(s) 2017-03-16T04:00:00Z 2017 3 2017-03-16T04:00:00Z   2017-03-16T16:18:58Z   0 0 09000064824f3b35
FDA-2016-N-2527-0261 FDA None FDA-2016-N-2527 Request to Extend Comment Period from Cheyenne International, LLC Other Request for Extension 2017-03-16T04:00:00Z 2017 3 2017-03-16T04:00:00Z   2017-03-16T16:20:12Z   0 0 0900006482504f00
FDA-2016-N-2527-0226 FDA None FDA-2016-N-2527 TAB B 2015-1102 Smokeless NNN Proposed Rule Track Changes re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:49:58Z   0 0 09000064824a3365
FDA-2016-N-2527-0227 FDA None FDA-2016-N-2527 TAB C 2015-1102 Smokeless NNN PRIA as Cleared by OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:50:06Z   0 0 09000064824a3366
FDA-2016-N-2527-0223 FDA None FDA-2016-N-2527 TAB A 2015-1102 Smokeless NNN PRIA as Submitted to OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:49:33Z   0 0 09000064824a3362
FDA-2016-N-2527-0224 FDA None FDA-2016-N-2527 TAB A 2015-1102 Smokeless NNN Proposed Rule as Submitted to OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:49:43Z   0 0 09000064824a3363
FDA-2016-N-2527-0222 FDA None FDA-2016-N-2527 Memorandum to FDA DDM Tobacco Smokeless NNN Proposed Rule re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:49:25Z   0 0 09000064824a3361
FDA-2016-N-2527-0225 FDA None FDA-2016-N-2527 TAB B 2015-1102 Smokeless NNN PRIA Track Changes re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:49:51Z   0 0 09000064824a3364
FDA-2016-N-2527-0228 FDA None FDA-2016-N-2527 TAB C 2015-1102 Smokeless NNN Proposed Rule as Cleared by OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-31T05:00:00Z 2017 1     2017-02-07T14:50:13Z   0 0 09000064824a3367
FDA-2016-N-2527-0114 FDA None FDA-2016-N-2527 Reference 107 - Hecht-2016-Exposure and Metabolic Activation B re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:46:36Z   0 0 090000648248ec25
FDA-2016-N-2527-0117 FDA None FDA-2016-N-2527 Reference 110 - Stockwell, Impact of Smoking and Smokeless re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:46:50Z   0 0 090000648248ec28
FDA-2016-N-2527-0121 FDA None FDA-2016-N-2527 Reference 114 - Lee-2009-Systematic Review of the Relation Bet re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:47:09Z   0 0 090000648248ec33
FDA-2016-N-2527-0204 FDA None FDA-2016-N-2527 Reference 198 - Mirvish, 1975, Formation of N-Nitroso Compounds re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:54:38Z   0 0 090000648248ecd5
FDA-2016-N-2527-0055 FDA None FDA-2016-N-2527 Reference 48 - Morin, et al, Evolution of Tobacco Specific Ni re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:41:52Z   0 0 090000648248ee8b
FDA-2016-N-2527-0092 FDA None FDA-2016-N-2527 Reference 85 - Digard-2013-Multi-Analyte Approach for Determi re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:44:54Z   0 0 090000648248eee3
FDA-2016-N-2527-0129 FDA None FDA-2016-N-2527 Reference 122 - Zhou-2013-Smokeless Tobacco and Risk of Head a re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:47:46Z   0 0 090000648248f04c
FDA-2016-N-2527-0133 FDA None FDA-2016-N-2527 Reference 126 - Yanovitzky-2000-Effect of Media Coverage and P re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:48:03Z   0 0 090000648248f052
FDA-2016-N-2527-0134 FDA None FDA-2016-N-2527 Reference 127 - Cram-2003-The Impact of a Celebrity Promotiona re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:48:08Z   0 0 090000648248f053
FDA-2016-N-2527-0197 FDA None FDA-2016-N-2527 Reference 191 - Boffetta, 2005, Smokeless Tobacco Use and Risk of Pancreatic Cancer re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:54:01Z   0 0 090000648248f0da
FDA-2016-N-2527-0026 FDA None FDA-2016-N-2527 Reference 19 - Foulds-2008-Is Low-Nicotine Marlboro Snus Real re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:39:29Z   0 0 090000648248ede3
FDA-2016-N-2527-0037 FDA None FDA-2016-N-2527 Reference 30 - Brunnemann-1996-Formation and Analysis of Toba re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:40:24Z   0 0 090000648248ee03
FDA-2016-N-2527-0043 FDA None FDA-2016-N-2527 Reference 36 - Burton-1994-Relationship Between Tobacco-Speci re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:40:51Z   0 0 090000648248ee12
FDA-2016-N-2527-0013 FDA None FDA-2016-N-2527 Reference 6 - Song-2016-Chemical and Toxicological Character re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:38:26Z   0 0 090000648248edc9
FDA-2016-N-2527-0067 FDA None FDA-2016-N-2527 Reference 60 - Hatsukami-1988-Topographical Features of Smoke re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:42:53Z   0 0 090000648248eebf
FDA-2016-N-2527-0098 FDA None FDA-2016-N-2527 Reference 91 - Brown, Patent US20050043515A1 re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:45:22Z   0 0 090000648248eeeb
FDA-2016-N-2527-0106 FDA None FDA-2016-N-2527 Reference 99 - Stepanov, 2005, Tobacco Specific Nitrosamines and re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:45:58Z   0 0 090000648248efd3
FDA-2016-N-2527-0131 FDA None FDA-2016-N-2527 Reference 124 - Chakravorty, B, Cessation Related Perceptions re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:47:54Z   0 0 090000648248f04e
FDA-2016-N-2527-0145 FDA None FDA-2016-N-2527 Reference 138 - Song-2009-Perceptions of Smoking-related Risks re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:49:17Z   0 0 090000648248f078
FDA-2016-N-2527-0153 FDA None FDA-2016-N-2527 Reference 147 - Hoffmann, 1990, Advances in Tobacco Carcinogenesis Chapt 3 re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:49:58Z   0 0 090000648248ec78
FDA-2016-N-2527-0156 FDA None FDA-2016-N-2527 Reference 150 - Prokopczyk, 1991, A Study of Betel Quid Carcinogenesis re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:50:13Z   0 0 090000648248ec7d
FDA-2016-N-2527-0183 FDA None FDA-2016-N-2527 Reference 177 - McIntee-2000-Metabolism of N'-nitrosonornicoti re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:52:53Z   0 0 090000648248ecad
FDA-2016-N-2527-0196 FDA None FDA-2016-N-2527 Reference 190 - Definition of cancer slope factor re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:53:56Z   0 0 090000648248f0d7
FDA-2016-N-2527-0212 FDA None FDA-2016-N-2527 Reference 206 - Stepanov, et al, Tobacco specific Nitrosamines in Smokeless re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:55:26Z   0 0 090000648248f0f8
FDA-2016-N-2527-0008 FDA None FDA-2016-N-2527 Reference 1 - IARC, Monographs on the Evaluation of Carcinogenic Risks re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:37:58Z   0 0 090000648248ed71
FDA-2016-N-2527-0078 FDA None FDA-2016-N-2527 Reference 71 - Jitnarin-2015-Tobacco Use Pattern among a Nati re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:43:46Z   0 0 090000648248ea81
FDA-2016-N-2527-0079 FDA None FDA-2016-N-2527 Reference 72 - Hecht, 2008, Exposure to Nicotine and Tobacco-specific re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:43:51Z   0 0 090000648248ea82
FDA-2016-N-2527-0111 FDA None FDA-2016-N-2527 Reference 104 - Idris, 1995, Toombak Dipping and Cancer of the Oral Cavity re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:46:20Z   0 0 090000648248ebd5
FDA-2016-N-2527-0053 FDA None FDA-2016-N-2527 Reference 46 - Staaf, Formation of Tobacco-specific Nitrosami re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:41:42Z   0 0 090000648248ee89
FDA-2016-N-2527-0064 FDA None FDA-2016-N-2527 Reference 57 - EPA, Risk Assessment Guidance re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:42:39Z   0 0 090000648248eeab
FDA-2016-N-2527-0105 FDA None FDA-2016-N-2527 Reference 98 - Hecht, 2007, Similar Exposure to a Tobacco-sp re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:45:54Z   0 0 090000648248efd2
FDA-2016-N-2527-0130 FDA None FDA-2016-N-2527 Reference 123 - Agaku, 2012, Evaluation of Factors Influencing re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Supporting & Related Material Background Material 2017-01-26T05:00:00Z 2017 1     2017-01-26T22:47:50Z   0 0 090000648248f04d

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 518.529ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API